tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CAREIT Expands Portfolio with Acquisition of Epiisod Macquarie Park in Australia

Story Highlights
CAREIT Expands Portfolio with Acquisition of Epiisod Macquarie Park in Australia

TipRanks Cyber Monday Sale

Centurion Corporation Limited ( (SG:OU8) ) has provided an announcement.

CAREIT has entered into a Forward Purchase Agreement to acquire Epiisod Macquarie Park, a PBSA asset in Australia, with the acquisition fully financed through committed loan facilities. The acquisition is contingent on the property’s completion by February 2026, and a master lease agreement is in place to ensure income stability until December 2027. This strategic move enhances CAREIT’s portfolio, which benefits from strong demand-supply dynamics in the PBWA and PBSA sectors, and positions the company for visible growth through active asset management and a global acquisition strategy.

The most recent analyst rating on (SG:OU8) stock is a Buy with a S$2.01 price target. To see the full list of analyst forecasts on Centurion Corporation Limited stock, see the SG:OU8 Stock Forecast page.

More about Centurion Corporation Limited

Centurion Accommodation REIT (CAREIT) is a real estate investment trust focused on investing in income-producing real estate assets primarily for purpose-built worker accommodation (PBWA) and purpose-built student accommodation (PBSA) globally, excluding Malaysia. It is listed on the SGX-ST and operates a diversified portfolio across 15 cities in 6 countries, with a strong presence in Singapore, the UK, and Australia.

Average Trading Volume: 2,071,281

Technical Sentiment Signal: Buy

Current Market Cap: S$1.44B

For an in-depth examination of OU8 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1